Commentary

Apple’s ResearchKit

Publish date: March 17, 2015

 

Dr. Benabio is a partner physician in the department of dermatology of the Southern California Permanente Group in San Diego, and volunteer clinical assistant professor at the University of California, San Diego. Dr. Benabio is @dermdoc on Twitter.

Pages

Recommended Reading

FDA approves palbociclib with letrozole for advanced postmenopausal breast cancer
MDedge Family Medicine
Breast cancer patients show poor adherence to cardiovascular, diabetes medications
MDedge Family Medicine
Lung cancer bypasses breast cancer as leading cause of cancer death for women in developed countries
MDedge Family Medicine
Stage trumps biology for most small triple-negative breast cancers
MDedge Family Medicine
Smoking linked to many ‘new’ causes of death
MDedge Family Medicine
Cancer mortality lowest in western United States
MDedge Family Medicine
More cancer patients surviving longer, but age-based disparities remain
MDedge Family Medicine
21-gene recurrence score assay underwent rapid uptake in U.S. breast cancer patients
MDedge Family Medicine
SEER: Breast cancer survivors at increased risk of thyroid cancer
MDedge Family Medicine
VIDEO: Following breast cancer diagnosis, risk of thyroid cancer rises
MDedge Family Medicine